Mycobacterium xenopi pulmonary infection in an HIV infected patient under highly active antiretroviral treatment.
Highly active antiretroviral therapy (HAART) is responsible for a striking reduction in AIDS related morbidity and mortality by partly restoring immune function. However, HAART can also precipitate the development of clinically apparent opportunistic infections in patients with latent infections. We report a case of an HIV infected patient who developed granulomatous nodular and cavitatory lesions of the lungs due to Mycobacterium xenopi as a manifestation of the immune restoration syndrome.
Bachmeyer
C
C
C Bachmeyer Département de Médecine Interne, Hôpital Laënnec, F-60109 Creil, France. claude.bachmeyer@ch-creil.fr
Blum
L
L
Stelianides
S
S
Benchaa
B
B
Gruat
N
N
Danne
O
O
D017088:AIDS-Related Opportunistic Infections / Q000150:complications*; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D004338:Drug Combinations; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D019259:Lamivudine / Q000627:therapeutic use; D008171:Lung Diseases / Q000209:etiology*; D009165:Mycobacterium Infections, Nontuberculous / Q000209:etiology*; D019912:Mycobacterium xenopi; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D004338:Drug Combinations; D019259:Lamivudine; D015215:Zidovudine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination